Drug Discovery Informatics Market Research Report: Information By Product (Discovery Informatics, Development Informatics), Mode (In-House Informatics and Outsourced Informatics), Service (Sequencing and Target Data Analysis, Docking, Molecular Modeling, Clinical Trial Data Management and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Table of Contents:

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6 Global Drug Discovery Informatics Market, by Product

6.1 Introduction

6.2 Discovery Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Development Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7 Global Drug Discovery Informatics Market, by Mode

7.1 Introduction

7.2 In-House Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Outsourced Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8 Global Drug Discovery Informatics Market, by Service

8.1 Introduction

8.2 Sequencing and Target Data Analysis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Docking

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Molecular Modeling

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Clinical Trial Data Management

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9 Global Drug Discovery Informatics Market, by End User

9.1 Introduction

9.2 Pharmaceutical and Biotechnology Industries

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3 Contract Research Organizations (CROs)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.4 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 10 Global Drug Discovery Informatics Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Developments & Strategies

Chapter 12 Company Profiles

12.1 Thermo Fisher Scientific, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financial Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategies

12.2 PerkinElmer, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.2.6 Key Strategies

12.3 Certara, L.P.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Developments

12.3.5 SWOT Analysis

12.3.6 Key Strategies

12.4 Infosys Limited

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.4.6 Key Strategies

12.5 Novo Informatics Pvt. Ltd.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.5.6 Key Strategies

12.6 Collaborative Drug Discovery Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.6.6 Key Strategies

12.7 Selvita

12.7.1 Company Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.7.6 Key Strategies

12.8 Charles River Laboratories, Inc.

12.8.1 Company Overview

12.8.2 Product Overview

12.8.3 Financial Overview

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.8.6 Key Strategies

12.9 International Business Machines Corporation

12.9.1 Company Overview

12.9.2 Product Overview

12.9.3 Financial Overview

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.9.6 Key Strategies

12.10 Jubilant Life Sciences Ltd.

12.10.1 Company Overview

12.10.2 Product Overview

12.10.3 Financial Overview

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.10.6 Key Strategies

12.11 IO Informatics, Inc.

12.11.1 Company Overview

12.11.2 Product Overview

12.11.3 Financial Overview

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.11.6 Key Strategies

12.12 GVK Biosciences Private Limited

12.12.1 Company Overview

12.12.2 Product Overview

12.12.3 Financial Overview

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.12.6 Key Strategies

12.13 Dassault Systèmes

12.13.1 Company Overview

12.13.2 Product Overview

12.13.3 Financial Overview

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.13.6 Key Strategies

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Drug Discovery Informatics Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Global Drug Discovery Informatics Market Synopsis, 2020–2027

Table 2 Global Drug Discovery Informatics Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Drug Discovery Informatics Market, by Region, 2020–2027 (USD Million)

Table 4 Global Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 5 Global Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 6 Global Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 7 Global Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 8 North America: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 9 North America: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 10 North America Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 11 North America: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 12 US: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 13 US: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 14 US: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 15 US: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 16 Canada: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 17 Canada: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 18 Canada: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 19 Canada: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 20 Latin America: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 21 Latin America: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 22 Latin America: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 23 Latin America: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 24 Europe: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 25 Europe: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 26 Europe: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 27 Europe: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 28 Western Europe: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 29 Western Europe: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 30 Western Europe: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 31 Western Europe: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 32 Eastern Europe: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 33 Eastern Europe: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 34 Eastern Europe: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 35 Eastern Europe: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 36 Asia-Pacific: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 37 Asia-Pacific: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 38 Asia-Pacific: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 39 Asia-Pacific: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 40 Middle East & Africa: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 41 Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 42 Middle East & Africa: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 43 Middle East & Africa: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Drug Discovery Informatics Market

Figure 3 Segmentation Market Dynamics for Global Drug Discovery Informatics Market

Figure 4 Global Drug Discovery Informatics Market Share, by Product, 2020

Figure 5 Global Drug Discovery Informatics Market Share, by Mode, 2020

Figure 6 Global Drug Discovery Informatics Market Share, by Service, 2020

Figure 7 Global Drug Discovery Informatics Market Share, by End User, 2020

Figure 8 Global Drug Discovery Informatics Market Share, by Region, 2020

Figure 9 North America: Drug Discovery Informatics Market Share, by Country, 2020

Figure 10 Europe: Drug Discovery Informatics Market Share, by Country, 2020

Figure 11 Asia-Pacific: Drug Discovery Informatics Market Share, by Country, 2020

Figure 12 Middle East & Africa: Drug Discovery Informatics Market Share, by Country, 2020

Figure 13 Global Drug Discovery Informatics Market: Company Share Analysis, 2020 (%)

Figure 14 Thermo Fisher Scientific, Inc.: Key Financials

Figure 15 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 16 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 17 PerkinElmer, Inc.: Key Financials

Figure 18 PerkinElmer, Inc.: Segmental Revenue

Figure 19 PerkinElmer, Inc.: Geographical Revenue

Figure 20 Certara, L.P.: Key Financials

Figure 21 Certara, L.P.: Segmental Revenue

Figure 22 Certara, L.P.: Geographical Revenue

Figure 23 Infosys Limited: Key Financials

Figure 24 Infosys Limited: Segmental Revenue

Figure 25 Infosys Limited: Geographical Revenue

Figure 26 Novo Informatics Pvt. Ltd.: Key Financials

Figure 27 Novo Informatics Pvt. Ltd.: Segmental Revenue

Figure 28 Novo Informatics Pvt. Ltd.: Geographical Revenue

Figure 29 Collaborative Drug Discovery Inc.: Key Financials

Figure 30 Collaborative Drug Discovery Inc.: Segmental Revenue

Figure 31 Collaborative Drug Discovery Inc.: Geographical Revenue

Figure 32 Selvita: Key Financials

Figure 33 Selvita: Segmental Revenue

Figure 34 Selvita: Geographical Revenue

Figure 35 Charles River Laboratories, Inc.: Key Financials

Figure 36 Charles River Laboratories, Inc.: Segmental Revenue

Figure 37 Charles River Laboratories, Inc.: Geographical Revenue

Figure 38 International Business Machines Corporation: Key Financials

Figure 39 International Business Machines Corporation: Segmental Revenue

Figure 40 International Business Machines Corporation: Geographical Revenue

Figure 41 Jubilant Life Sciences Ltd.: Key Financials

Figure 42 Jubilant Life Sciences Ltd.: Segmental Revenue

Figure 43 Jubilant Life Sciences Ltd.: Geographical Revenue

Figure 44 IO Informatics, Inc.: Key Financials

Figure 45 IO Informatics, Inc.: Segmental Revenue

Figure 46 IO Informatics, Inc.: Geographical Revenue

Figure 47 GVK Biosciences Private Limited: Key Financials

Figure 48 GVK Biosciences Private Limited: Segmental Revenue

Figure 49 GVK Biosciences Private Limited: Geographical Revenue

Figure 50 Dassault Systèmes: Key Financials

Figure 51 Dassault Systèmes: Segmental Revenue

Figure 52 Dassault Systèmes: Geographical Revenue